Tag: FDA-approved

April 5, 2017

Corbus To Begin Phase 3 Study Of Anabasum

Corbus Pharmaceuticals Holdings announced it will be moving forward with a Phase 3 study for Anabasum to treat Systemic Sclerosis,...
April 4, 2017

AMAG Closes Exclusive Licensing Agreement For Rights To Intrarosa

AMAG Pharmaceuticals (NASDAQ:AMAG) closed a licensing agreement with Endoceutics for the US commercial rights to Intrarosa, (prasterone).
March 30, 2017

Mateon Releases Financial Results For 2016

Mateon Therapeutics (OTCQX: MATN) posted its financial results for 2016 and gave out an update on the company and its...
March 29, 2017

Ritter Reports New Results in Lactose Intolerance Trial

Ritter Pharmaceuticals (NASDAQ:RTTR) announced new findings from its Phase 2b/3 studies for RP-G28 treating subjects with lactose intolerance.
March 29, 2017

VistaGen Obtains European Patent For AV-101

VistaGen Therapeutics announced the European Patent Office issued a notice of intention to grant the company's European patent application for...
November 9, 2015

10 Uses of Medical Marijuana

What specific ailments are people treating with marijuana? The list is lengthy, but here's a brief look at 10 common...